Breaking research

Gender Disparities in Lyme Disease: Women Face Higher Risk of Severe and Prolonged Illness


Photo by Erik Karits on Pexels

Women with Lyme disease take longer to get diagnosed, have more severe symptoms and experience higher rates of disability when compared to men. They may also be more likely to develop persistent Lyme disease. Those are among the findings of a recent study that analyzed information from the MyLymeData patient registry. The results have been published in the International Journal of General Medicine.

The present study, which was conducted by LymeDisease.org, a research and advocacy organization, assessed sex-based differences in Lyme disease patients who remained ill for six months or more after antibiotic treatment. In addition to responses from 2,170 patients enrolled in MyLymeData, the researchers reviewed other Lyme disease studies to evaluate the distribution of patients by sex, stage of illness, data source, and enrollment criteria.

Analysis of the study data revealed several important insights. Women reported a higher prevalence of tick-borne co-infections, more severe symptoms, longer diagnostic delays, increased misdiagnoses, and greater functional impairment compared to men. However, no significant differences were observed in antibiotic treatment response or side effects. The majority of both men and women who were treated with antibiotics reported improvement.

Lyme disease is a tick-borne infection caused by Borrelia burgdorferi, a corkscrew-shaped bacteria known as a spirochete. The Centers for Disease Control and Prevention (CDC) estimates that over 476,000 people are diagnosed with the illness each year in the United States. That makes new cases of Lyme disease more common than breast cancer, HIV/AIDS and tuberculosis combined in this country.

According to LymeDisease.org CEO Lorraine Johnson, lead author of the study, “We need to find out why more women than men develop persistent Lyme disease. Our study shows that women are diagnosed later—which increases their risk of chronic illness. But we must also determine whether biological variables play a role as they do in other infectious diseases.”

“Science has ignored gender-based differences in research for far too long,” said Dr. Raphael Stricker, the study’s senior author. “Our findings underscore the need for greater consideration of gender-specific factors in Lyme disease research in order to improve outcomes for all patients.”

The study coauthors are Lorraine Johnson of LymeDisease.org, San Ramon, CA; Mira Shapiro of Analytic Designers LLC, Bethesda, MD; Sylvia Janicki of Georgia Institute of Technology, Atlanta, GA; Jennifer Mankoff of University of Washington, Seattle, WA; and Raphael Stricker of Union Square Medical Associates, San Francisco, CA.

About LymeDisease.org

LymeDisease.org is one of the nation's oldest Lyme disease advocacy organizations, as well as one of the community's largest and most trusted communications networks. We harness the power of tens of thousands of patients to improve patient care and accelerate Lyme disease research using science-based advocacy. We do this through our patient-led research project, MyLymeData, which allows patients to pool their data to accelerate research using real-world evidence. www.lymedisease.org

 

Additional Resources:

This study can be downloaded here.

To enroll in MyLymeData, visit www.MyLymeData.org .

For more information about findings from the registry, visit the MyLymeData Viz Blog.

 

About Taylor & Francis

Taylor & Francis supports diverse communities of experts, researchers and knowledge makers around the world to accelerate and maximize the impact of their work. We are a leader in our field, publish across all disciplines and have one of the largest Humanities and Social Sciences portfolios. Our expertise, built on an academic publishing heritage of over 200 years, advances trusted knowledge that fosters human progress.

Our 2650 people, based in a global network of offices in 17 countries, use their skills and the latest technology to curate, validate and share impactful advanced, emergent and applied knowledge. Under the Taylor & Francis, Routledge and F1000 imprints we publish 2700 journals, 8000 new books each year and partner with more than 700 scholarly societies.

Taylor & Francis is proud to be a Global Certified Accessible™ publisher and to have achieved CarbonNeutral® certification for our operations and print publications in accordance with The CarbonNeutral Protocol.